Buy Glenmark Pharma, stock may touch 390: Ashwani Gujral, Ashwanigujral.com

In a chat with ET Now, Ashwani Gujral, Fund Manager, Ashwanigujral.com, shares his views on Glenmark Pharma.

ET Now: What is the call on Glenmark Pharma?

Ashwani Gujral: Glenmark Pharma is coming out of a large consolidation. We can stay past 350. Chances are that investors can get closer to levels of about 390. Pharmaceuticals continues to remain as a theme, although different stocks seem to be performing at different times.